Measles-containing-vaccine second-dose (MCV2) … MCV2, WUENIC in Senegal
Senegal: Measles-containing-vaccine second-dose (MCV2) immunization coverage was 78.0% in 2025. ◆ Volatile
Measles-containing-vaccine second-dose (MCV2) immunization coverage in Senegal, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
In 2025, measles-containing-vaccine second-dose (mcv2) immunization coverage in Senegal stood at 78.0%.
That represents a change of down 1.3% on the previous year and up 44.4% over ten years.
Over the whole period, measles-containing-vaccine second-dose (mcv2) immunization coverage in Senegal peaked at 79.0% in 2024 and was at its lowest, 0.0%, in 2000.
That places Senegal 117th out of 194 countries with data for 2025, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Measles-containing-vaccine second-dose (MCV2) immunization coverage in Senegal, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 0.0% | — |
| 2006 | 0.0% | — |
| 2007 | 0.0% | — |
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 0.0% | — |
| 2011 | 0.0% | — |
| 2012 | 0.0% | — |
| 2013 | 0.0% | — |
| 2014 | 13.0% | — |
| 2015 | 54.0% | +315.4% |
| 2016 | 57.0% | +5.6% |
| 2017 | 59.0% | +3.5% |
| 2018 | 62.0% | +5.1% |
| 2019 | 63.0% | +1.6% |
| 2020 | 63.0% | +0.0% |
| 2021 | 64.0% | +1.6% |
| 2022 | 69.0% | +7.8% |
| 2023 | 74.0% | +7.2% |
| 2024 | 79.0% | +6.8% |
| 2025 | 78.0% | -1.3% |
Senegal compared with similar countries
- Senegal's 78.0% is above the median for lower middle income countries, which is 70.0%, 1.1× the median. (47 countries reporting)
- Senegal's 78.0% is above the median for Sub-Saharan Africa, which is 66.0%, 1.2× the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 10 |
| 2010s | 30.8% | 0.0% | 63.0% | 10 |
| 2020s | 71.2% | 63.0% | 79.0% | 6 |
Countries ranked near Senegal
More health data for Senegal
- Un projection of annual infant deaths, annual growth rate -1.58 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.7598 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 835.5 deaths per 1,000 people (2090)
- Number of infants who die before age 1 2,496 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 3 (2025)
- Population ages 00-04, female, annual growth rate 2.42 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0658 units per person (2025)
- Population ages 00-04, male, annual growth rate 1.29 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is measles-containing-vaccine second-dose (mcv2) immunization coverage in Senegal?
- Measles-containing-vaccine second-dose (mcv2) immunization coverage in Senegal was 78.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Senegal?
- The highest recorded value was 79.0% in 2024.
- What is the lowest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Senegal?
- The lowest recorded value was 0.0% in 2000.
- How does Senegal rank for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Senegal ranks 117th out of 194 countries with data for 2025.
- Is measles-containing-vaccine second-dose (mcv2) immunization coverage rising or falling in Senegal?
- Over the last ten years it is up 44.4%. The long-run trend across the full record is volatile.
- Where does this Senegal data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).